Kronos Bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Kronos Bio, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $5.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-18.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2025-03-18
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $5.00K.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $13.00K.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $53.00K.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $11.72M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2024-12-31 | $5.00K 10-K · filed 2025-03-18 |
| 2023-12-31 | $13.00K 10-K · filed 2024-03-21 |
| 2022-12-31 | $53.00K 10-K · filed 2023-03-15 |
| 2021-12-31 | $11.72M 10-K · filed 2022-02-24 |
| 2020-12-31 | $8.19M 10-K · filed 2021-03-23 |
| 2020-09-30 | $1.10M 10-Q · filed 2020-11-18 |